SCHEMBL3889186

SCHEMBL3889186

Cc1cc(Sc2sc(-c3ccc(C(F)(F)F)cc3)nc2C)ccc1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 20/20 0.49
PPARA Q07869 9/20 0.49
PPARG P37231 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3954490 0.84 PPARD (0.68) PPARDPPARAPPARG
SCHEMBL3889190 0.83 TRPA1 (0.36) PPARDPPARAPPARG
SCHEMBL5673868 0.81 PPARD (0.48) PPARDPPARAPPARG
SCHEMBL5673869 0.80 PPARD (0.47) PPARDPPARAPPARG
SCHEMBL3962325 0.80 PPARD (0.75) PPARDPPARAPPARG
SCHEMBL2167562 0.77 PPARD (0.66) PPARDPPARAPPARG
SCHEMBL5482061 0.76 PPARD (0.70) PPARDPPARAPPARG
SCHEMBL4183761 0.74 PPARD (0.75) PPARDPPARA
SCHEMBL15142266 0.73 PPARD (0.55) PPARDPPARAPPARG
SCHEMBL5272530 0.73 PPARD (0.59) PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264660-A1 PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS Kang, Heonjoong (KR) 2009-10-22 US claimed
EP-1812386-A1 PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS Kang, Heonjoong (KR) 2007-08-01 EP claimed
WO-2006043797-A1 PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS KANG HEONJOONG (KR) 2006-04-27 WO claimed
US-20090264660-A1 PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS Kang, Heonjoong (KR) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264660-A1 PROCESS FOR ALKYL ARYL SULFIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS TST, ARSA, STS PPARD 2538/4885PPARA 1900/4885PPARG 623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.